Evidence map›Paper›PMID 16611216›Full record

ArticleChemical biology & drug design2006

Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.

Etienne Tokonzaba, Daniel G S Capelluto, Tatiana G Kutateladze, Michael Overduin

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Chemical biology & drug design, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. A signalling cascade involving receptor-activated phospholipase ACell communication and signaling : CCS · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Motif mediated protein-protein interactions as drug targets.Cell communication and signaling : CCS · 2016
    Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Etienne TokonzabaDepartment of Pharmacology, University of Colorado Health Sciences Center,12801 East 17th Avenue, Aurora, CO 80045, USA.
Daniel G S Capelluto
Tatiana G Kutateladze
Michael Overduin
University of Birmingham · GBUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Health · USVirginia Tech · US

Funding

Biotechnology and Biological Sciences Research Council BBS/B/10714Cancer Research UK A4592Wellcome Trust 071684
6 · The paper itself

Abstract

Signaling proteins are localized and regulated by Src homology 2 domains which recognize phosphotyrosine-containing sequences. Recently, noncanonical ligands have been proposed for Src homology 2 domains including that of Abl and its breakpoint cluster region fusion, which causes chronic myelogenous leukemia. Here, the Abl Src homology 2 domain's binding sites and affinities for phosphotyrosine- and phosphoserine-containing motifs, phosphoinositides as well as a pyridone-based peptidomimetic inhibitor were determined using nuclear magnetic resonance spectroscopy in order to define their roles. The cognate Crk peptide ligand was bound with an affinity of 69 microM and, like the higher affinity peptidomimetic, engages the phosphotyrosine and +3 hydrophobic pockets while putative phosphoserine-containing breakpoint cluster region ligands are ruled out. Surprisingly, phosphatidylinositol 4, 5 bisphosphate interacts with an overlapping site through an electrostatic mechanism that does not appear to involve hydrophobic insertion into micelles. The conserved Arg36 residue in the FLVRES motif is required for both phosphotyrosine binding and for localization to phosphatidylinositol 4, 5 bisphosphate-containing liposomes, while Arg59 in the betaD strand is necessary for the phosphoinositide interaction. Thus the Src homology 2 domain of Abl, a myristoylated and membrane-localized protein, is able to interact directly with phosphoinositides through a multifunctional basic site that overlaps the phosphotyrosine pocket.

Indexed as

src Homology DomainsAnimalsLigandsMagnetic Resonance SpectroscopyMembrane ProteinsMiceMicellesMutagenesis, Site-DirectedMyristic AcidPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphopeptidesPhosphotyrosineProto-Oncogene Proteins c-ablPyridonesLigandsMembrane ProteinsMicellesMyristic AcidPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphopeptidesPhosphotyrosineProto-Oncogene Proteins c-ablPyridones

Identifiers

PMID16611216
PMCPMC2610419
OpenAlexW2118944773

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.